|
1
|
Dorfman HD and Czerniak B: Bone cancers.
Cancer. 75:203–210. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rytting M, Pearson P, Raymond AK, Ayala A,
Murray J, Yasko AW, Johnson M and Jaffe N: Osteosarcoma in
preadolescent patients. Clin Orthop Relat Res. 373:39–50. 2000.
View Article : Google Scholar
|
|
3
|
Longhi A, Errani C, De Paolis M, Mercuri M
and Bacci G: Primary bone osteosarcoma in the pediatric age: state
of the art. Cancer Treat Rev. 32:423–436. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hudson M, Jaffe MR, Jaffe N, Ayala A,
Raymond AK, Carrasco H, Wallace S, Murray J and Robertson R:
Pediatric osteosarcoma: therapeutic strategies, results and
prognostic factors derived from a 10-year experience. J Clin Oncol.
8:1988–1997. 1990.PubMed/NCBI
|
|
5
|
Desandes E: Survival from adolescent
cancer. Cancer Treat Rev. 33:609–615. 2007. View Article : Google Scholar
|
|
6
|
Fellenberg J, Mau H, Nedel S, Ewerbeck V
and Debatin KM: Drug-induced apoptosis in osteosarcoma cell lines
is mediated by caspase activation independent of
CD95-receptor/ligand interaction. J Orthop Res. 18:10–17. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seki K, Yoshikawa H, Shiiki K, Hamada Y,
Akamatsu N and Tasaka K: Cisplatin (CDDP) specifically induces
apoptosis via sequential activation of caspase-8, -3 and -6 in
osteosarcoma. Cancer Chemother Pharmacol. 45:199–206. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fu W, Ma L, Chu B, Wang X, Bui MM, Gemmer
J, Altiok S and Pledger WJ: The cyclin-dependent kinase inhibitor
SCH 727965 (dinacliclib) induces the apoptosis of osteosarcoma
cells. Mol Cancer Ther. 10:1018–1027. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ashkenazi A and Dixit VM: Death receptors:
signaling and modulation. Science. 281:1305–1308. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Deveraux QL, Takahashi R, Salvesen GS and
Reed JC: X-linked IAP is a direct inhibitor of cell-death
proteases. Nature. 388:300–304. 1997. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Broker LE, Kruyt FA and Giaccone G: Cell
death independent of caspases: a review. Clin Cancer Res.
11:3155–3162. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cande C, Cecconi F, Dessen P and Kroemer
G: Apoptosis-inducing factor (AIF): key to the conserved
caspase-independent pathways of cell death? J Cell Sci.
115:4727–4734. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bursch W: The autophagosomal-lysosomal
compartment in programmed cell death. Cell Death Differ. 8:569–581.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tsujimoto Y and Shimizu S: Another way to
die: autophagic programmed cell death. Cell Death Differ.
12:1528–1534. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Grinde B: Autophagy and lysosomal
proteolysis in the liver. Experientia. 41:1089–1095. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lum JJ, Bauer DE, Kong M, Harris MH, Li C,
Lindsten T and Thompson CB: Growth factor regulation of autophagy
and cell survival in the absence of apoptosis. Cell. 120:237–248.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Gutierrez MG, Master SS, Singh SB, Taylor
GA, Colombo MI and Deretic V: Autophagy is a defense mechanism
inhibiting BCG and Mycobacterium tuberculosis survival in infected
macrophages. Cell. 119:753–766. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu L, Alva A, Su H, Dutt P, Freundt E,
Welsh S, Baehrecke EH and Lenardo MJ: Regulation of an ATG7-beclin
1 program of autophagic cell death by caspase-8. Science.
304:1500–1502. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shimizu S, Kanaseki T, Mizushima N, Mizuta
T, Arakawa-Kobayashi S, Thompson CB and Tsujimoto Y: Role of Bcl-2
family proteins in a non-apoptotic programmed cell death dependent
on autophagy genes. Nat Cell Biol. 6:1221–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paludan C, Schmid D, Landthaler M,
Vockerodt M, Kube D, Tuschl T and Münz C: Endogenous MHC class II
processing of a viral nuclear antigen after autophagy. Science.
307:593–596. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Komatsu M, Waguri S, Chiba T, Murata S,
Iwata J, Tanida I, Ueno T, Koike M, Uchiyama Y, Kominami E and
Tanaka K: Loss of autophagy in the central nervous system causes
neurodegeneration in mice. Nature. 441:880–884. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mathew R, Karantza-Wadsworth V and White
E: Role of autophagy in cancer. Nat Rev Cancer. 7:961–967. 2007.
View Article : Google Scholar
|
|
24
|
Rowinsky EK, Onetto N, Canetta RM and
Arbuck SG: Taxol: the first of the taxanes, an important new class
of antitumor agents. Semin Oncol. 19:646–662. 1992.PubMed/NCBI
|
|
25
|
Ringel I and Horwitz SB: Effect of
alkaline pH on taxol-microtubule interactions. J Pharmacol Exp
Ther. 259:855–860. 1991.PubMed/NCBI
|
|
26
|
Anninga JK, Gelderblom H, Fiocco M, Kroep
JR, Taminiau AH, Hogendoorn PC and Egeler RM: Chemotherapeutic
adjuvant treatment for osteosarcoma: where do we stand? Eur J
Cancer. 47:2431–2445. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Saloustros E, Mavroudis D and Georgoulias
V: Paclitaxel and docetaxel in the treatment of breast cancer.
Expert Opin Pharmacother. 9:2603–2616. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chu Q, Vincent M, Logan D, Mackay JA and
Evans WK: Lung Cancer Disease Site Group of Cancer Care Ontario’s
Program in Evidence-based Care. Taxanes as first-line therapy for
advanced non-small cell lung cancer: a systematic review and
practice guideline. Lung Cancer. 50:355–374. 2005.
|
|
29
|
Obasaju C and Hudes GR: Paclitaxel and
docetaxel in prostate cancer. Hematol Oncol Clin North Am.
15:525–545. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Young M and Plosker GL: Paclitaxel: a
pharmacoeconomic review of its use in the treatment of ovarian
cancer. Pharmacoeconomics. 19:1227–1259. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weigel TL, Lotze MT, Kim PK, Amoscato AA,
Luketich JD and Odoux C: Paclitaxel-induced apoptosis in non-small
cell lung cancer cell lines is associated with increased caspase-3
activity. J Thorac Cardiovasc Surg. 119:795–803. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Blajeski AL, Kottke TJ and Kaufmann SH: A
multistep model for paclitaxel-induced apoptosis in human breast
cancer cell lines. Exp Cell Res. 270:277–288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim JY, Chung JY, Lee SG, Kim YJ, Park JE,
Yoo KS, Yoo YH, Park YC, Kim BG and Kim JM: Nuclear interaction of
Smac/DIABLO with Survivin at G2/M arrest prompts docetaxel-induced
apoptosis in DU145 prostate cancer cells. Biochem Biophys Res
Commun. 350:949–954. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Pucci B, Bellincampi L, Tafani M,
Masciullo V, Melino G and Giordano A: Paclitaxel induces apoptosis
in Saos-2 cells with CD95L upregulation and Bcl-2 phosphorylation.
Exp Cell Res. 252:134–143. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lu KH, Lue KH, Chou MC and Chung JG:
Paclitaxel induces apoptosis via caspase-3 activation in human
osteogenic sarcoma cells (U-2 OS). J Orthop Res. 23:988–994. 2005.
View Article : Google Scholar
|
|
36
|
Kovar J, Ehrlichov M, Smejkalov B, Zanardi
I, Ojima I and Gut I: Comparison of cell death-inducing effect of
novel taxane SB-T-1216 and paclitaxel in breast cancer cells.
Anticancer Res. 29:2951–2960. 2009.PubMed/NCBI
|
|
37
|
Osaki S, Nakanishi Y, Takayama K, Pei XH,
Ueno H and Hara N: Transfer of IkappaBalpha gene increase the
sensitivity of paclitaxel mediated with caspase 3 activation in
human lung cancer cell. J Exp Clin Cancer Res. 22:69–75.
2003.PubMed/NCBI
|
|
38
|
Ueno NT, Bartholomeusz C, Herrmann JL and
Estrov Z: E1A-mediated paclitaxel sensitization in
HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis
involving the caspase-3 pathway. Clin Cancer Res. 6:250–259.
2000.PubMed/NCBI
|
|
39
|
Huisman C, Ferreira CG, Broker LE,
Rodriguez JA, Smit EF, Postmus PE, Kruyt FA and Giaccone G:
Paclitaxel triggers cell death primarily via caspase-independent
routes in the non-small cell lung cancer cell line NCI-H460. Clin
Cancer Res. 8:596–606. 2002.PubMed/NCBI
|
|
40
|
Ofir R, Seidman R, Rabinski T, Krup M,
Yavelsky V, Weinstein Y and Wolfson M: Taxol-induced apoptosis in
human SKOV3 ovarian and MCF7 breast carcinoma cells is caspase-3
and caspase-9 independent. Cell Death Differ. 9:636–642. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Vikhanskaya F, Vignati S, Beccaglia P,
Ottoboni C, Russo P, D’Incalci M and Broggini M: Inactivation of
p53 in a human ovarian cancer cell line increases the sensitivity
to paclitaxel by inducing G2/M arrest and apoptosis. Exp Cell Res.
241:96–101. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sasaki H, Sheng Y, Kotsuji F and Tsang BK:
Down-regulation of X-linked inhibitor of apoptosis protein induces
apoptosis in chemoresistant human ovarian cancer cells. Cancer Res.
60:5659–5666. 2000.PubMed/NCBI
|
|
43
|
Fellenberg J, Kunz P, Suhr H and Depeweg
D: Overexpression of inosine 5′-monophosphate dehydrogenase type II
mediates chemoresistance to human osteosarcoma cells. PLoS One.
5:e121792010.
|
|
44
|
Kimmelman AC: The dynamic nature of
autophagy in cancer. Genes Dev. 25:1999–2010. 2011. View Article : Google Scholar
|
|
45
|
Rubinsztein DC, Mariño G and Kroemer G:
Autophagy and aging. Cell. 146:682–695. 2011. View Article : Google Scholar
|
|
46
|
Jung HS and Lee MS: Role of autophagy in
diabetes and mitochondria. Ann NY Acad Sci. 1201:79–83. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Nemchenko A, Chiong M, Turer A, Lavandero
S and Hill JA: Autophagy as a therapeutic target in cardiovascular
disease. J Mol Cell Cardiol. 51:584–593. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Levine B, Mizushima N and Virgin HW:
Autophagy in immunity and inflammation. Nature. 469:323–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Alirezaei M, Kemball CC and Whitton JL:
Autophagy, inflammation and neurodegenerative disease. Eur J
Neurosci. 33:197–204. 2011. View Article : Google Scholar
|
|
50
|
Yu L, Strandberg L and Lenardo MJ: The
selectivity of autophagy and its role in cell death and survival.
Autophagy. 4:567–573. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Seglen PO and Gordon PB: 3-Methyladenine:
specific inhibitor of autophagic/lysosomal protein degradation in
isolated rat hepatocytes. Proc Natl Acad Sci USA. 79:1889–1892.
1982. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Xi G, Hu X, Wu B, Jiang H, Young CY, Pang
Y and Yuan H: Autophagy inhibition promotes paclitaxel-induced
apoptosis in cancer cells. Cancer Lett. 307:141–148. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Li J, Hou N, Faried A, Tsutsumi S and
Kuwano H: Inhibition of autophagy augments 5-fluorouracil
chemotherapy in human colon cancer in vitro and in vivo model. Eur
J Cancer. 46:1900–1909. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Herman-Antosiewicz A, Johnson DE and Singh
SV: Sulforaphane causes autophagy to inhibit release of cytochrome
C and apoptosis in human prostate cancer cells. Cancer Res.
66:5828–5835. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Shingu T, Fujiwara K, Bugler O, Akiyama Y,
Moritake K, Shinojima N, Tamada Y, Yokoyama T and Kondo S:
Inhibition of autophagy at a late stage enhances imatinib-induced
cytotoxicity in human malignant glioma cells. Int J Cancer.
124:1060–1071. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Carew JS, Nawrocki ST, Kahue CN, Zhang H,
Yang C, Chung L, Houghton JA, Huang P, Giles FJ and Cleveland JL:
Targeting autophagy augments the anticancer activity of the histone
deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug
resistance. Blood. 110:313–322. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Levine B, Sinha S and Kroemer G: Bcl-2
family members: dual regulators of apoptosis and autophagy.
Autophagy. 4:600–606. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Tanida I, Minematsu-Ikeguchi N, Ueno T and
Kominami E: Lysosomal turnover, but not a cellular level, of
endogenous LC3 is a marker for autophagy. Autophagy. 1:84–91. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Ohsumi Y: Molecular dissection of
autophagy: two ubiquitin-like systems. Nat Rev Mol Cell Biol.
2:211–216. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kabeya Y, Mizushima N, Ueno T, Yamamoto A,
Kirisako T, Noda T, Kominami E, Ohsumi Y and Yoshimori T: LC3, a
mammalian homologue of yeast Apg8p, is localized in autophagosome
membranes after processing. EMBO J. 19:5720–5728. 2000. View Article : Google Scholar : PubMed/NCBI
|
